Tubulin beta 5 is not the target of antineutrophil antibodies in primary sclerosing cholangitis

Clin Exp Immunol. 2024 Sep 16;218(1):75-77. doi: 10.1093/cei/uxae053.

Authors

Johannes R Hov^{1

2}, Øyvind Molberg^{2

3}, Tom H Karlsen^{1

2}

Affiliations

¹ Section of Gastroenterology, Norwegian PSC Research Center and Research Institute of Internal Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Oslo, Norway.
² Institute of Clinical Medicine, University of Oslo, Norway.
³ Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

PMID: 38960384
PMCID: PMC11404114 (available on 2025-07-03)
DOI: 10.1093/cei/uxae053

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Antineutrophil Cytoplasmic* / immunology
Cholangitis, Sclerosing* / immunology
Female
Humans
Male
Middle Aged
Tubulin* / immunology

Substances

Antibodies, Antineutrophil Cytoplasmic
Tubulin